相似文献
1
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth.
Oncoimmunology. 2012 Nov 1;1(8):1433-1434. doi: 10.4161/onci.21176.
2
Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
J Invest Dermatol. 2012 Apr;132(4):1239-46. doi: 10.1038/jid.2011.416. Epub 2011 Dec 22.
3
Myeloid-derived suppressor cells promote age-related increase of lung cancer growth via B7-H1.
Exp Gerontol. 2015 Jan;61:84-91. doi: 10.1016/j.exger.2014.12.001. Epub 2014 Dec 2.
4
Myeloid derived suppressor cells and their role in tolerance induction in cancer.
J Dermatol Sci. 2010 Jul;59(1):1-6. doi: 10.1016/j.jdermsci.2010.05.001.
5
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
J Immunol. 2012 Dec 15;189(12):5602-11. doi: 10.4049/jimmunol.1201018. Epub 2012 Nov 14.
6
Myeloid-derived Suppressor Cells Recruit CD4(+)/Foxp3(+) Regulatory T Cells in a Murine Cardiac Allograft.
Transplant Proc. 2016 May;48(4):1275-8. doi: 10.1016/j.transproceed.2015.10.060.
7
Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.
Innate Immun. 2019 Jan;25(1):46-59. doi: 10.1177/1753425918820427.
8
B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
Clin Immunol. 2008 Dec;129(3):471-81. doi: 10.1016/j.clim.2008.07.030. Epub 2008 Sep 14.
9
Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Blood Rev. 2016 Sep;30(5):341-8. doi: 10.1016/j.blre.2016.04.002. Epub 2016 Apr 12.
10
Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
Int J Mol Sci. 2021 May 25;22(11):5587. doi: 10.3390/ijms22115587.
引用本文的文献
1
Cellular Senescence and Immunosenescence in Melanoma: Insights From the Tumor Microenvironment.
Cancer Med. 2025 Sep;14(17):e71223. doi: 10.1002/cam4.71223.
2
Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma.
J Immunother Cancer. 2025 Apr 9;13(4):e010352. doi: 10.1136/jitc-2024-010352.
3
CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype.
J Exp Clin Cancer Res. 2025 Apr 4;44(1):113. doi: 10.1186/s13046-025-03286-x.
4
Burning lactic acid: a road to revitalizing antitumor immunity.
Front Med. 2025 Mar 22. doi: 10.1007/s11684-025-1126-6.
5
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer.
Front Immunol. 2024 Dec 10;15:1455211. doi: 10.3389/fimmu.2024.1455211. eCollection 2024.
6
The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder.
Biomolecules. 2024 Aug 22;14(8):1042. doi: 10.3390/biom14081042.
7
Tumor antigen‑specific interleukin‑10‑producing T‑cell response in patients with head and neck squamous cell carcinoma.
Oncol Lett. 2024 Jul 24;28(4):456. doi: 10.3892/ol.2024.14589. eCollection 2024 Oct.
8
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
Int J Oncol. 2024 Sep;65(3). doi: 10.3892/ijo.2024.5673. Epub 2024 Jul 26.
9
A review of lactate-lactylation in malignancy: its potential in immunotherapy.
Front Immunol. 2024 May 8;15:1384948. doi: 10.3389/fimmu.2024.1384948. eCollection 2024.
10
Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
Front Immunol. 2024 Apr 5;15:1375767. doi: 10.3389/fimmu.2024.1375767. eCollection 2024.
本文引用的文献
1
Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.
Acta Derm Venereol. 2012 Nov;92(6):625-8. doi: 10.2340/00015555-1453.
2
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate.
Case Rep Dermatol. 2012 Jan;4(1):5-9. doi: 10.1159/000335999. Epub 2012 Jan 11.
3
Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
J Invest Dermatol. 2012 Apr;132(4):1239-46. doi: 10.1038/jid.2011.416. Epub 2011 Dec 22.
4
Myeloid derived suppressor cells and their role in tolerance induction in cancer.
J Dermatol Sci. 2010 Jul;59(1):1-6. doi: 10.1016/j.jdermsci.2010.05.001.
5
IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.
J Immunol. 2010 Jun 15;184(12):7144-53. doi: 10.4049/jimmunol.0902739. Epub 2010 May 10.
6
Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma.
Cancer. 2010 Apr 1;116(7):1757-66. doi: 10.1002/cncr.24899.
7
Immune responses to malignancies.
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S272-83. doi: 10.1016/j.jaci.2009.09.045. Epub 2010 Jan 12.
8
Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC.
Eur J Immunol. 2010 Feb;40(2):321-9. doi: 10.1002/eji.200939527.
9
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51. doi: 10.1073/pnas.0706832104. Epub 2007 Nov 27.
10
Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer.
Cancer Res. 2004 Aug 15;64(16):5535-8. doi: 10.1158/0008-5472.CAN-04-1272.
Zotero 插件